Home
Contact Us
About Us
Advertise
Biotech
Finance
Tech News
Disclaimer
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
BioPharmaJournal
Home
Contact Us
About Us
Advertise
Biotech
Hoth Therapeutics ($HOTH) Advances to Phase 2a Trials with New Skin…
Atara Biotherapeutics (ATRA) Secures Strategic Investments to Advance T-cell Immunotherapy Innovations
SPAR Group to Go Private in $2.50 Per Share Buyout by…
BioCardia Inc (Nasdaq: BCDA) Achieves Significant FDA Clearance for Morph DNA…
XORTX Therapeutics Inc ($XRTX): Pioneering New Treatments for Kidney Disease with…
Finance
Portage Biotech Inc. (NASDAQ: PRTG): A Closer Look at a Tumultuous…
Avalon GloboCare (ALBT) surges post Launch of Innovative Male Incontinence Device
Reason why Inspirato Incorporated (ISPO) has high trading volume today
Clearmind Medicine Inc (CMND) briefly surges and here’s why
Actinium Pharmaceuticals (ATNM): Poised for Growth? Targeted Radiotherapy Conditioning Agent Shows…
Tech News
Aehr Test Systems (NASDAQ: AEHR) Receives an Order of $10.8 Million…
Tauriga Sciences Inc (OTCMKTS:TAUG) Could React on New Aegea Rapid Test…
Micro and Macro Tailwinds Converge for KULR
ISWH and the Rebirth of the Crypto Cycle
Disclaimer
Home
Tags
SRNE News
Tag: SRNE News
Sorrento Therapeutics Inc. (NASDAQ: SRNE) Closes The Acquisition of Virex Health...
Gavins Felicity
-
February 7, 2022
0
Sorrento Therapeutics Inc. (NASDAQ: SRNE) and Sorrento Mexico Receive EUA from...
Kate Hudson
-
February 1, 2022
0
Sorrento Therapeutics Inc. (NASDAQ: SRNE) Receives Approval From ANVISA To Commence...
Kate Hudson
-
January 25, 2022
0
Sorrento Therapeutics Inc. (NASDAQ: SRNE) Announce That Preliminary Test Results Show...
Gavins Felicity
-
January 4, 2022
0
Sorrento Therapeutics Inc. (NASDAQ: SRNE) receives FDA Clearance for Phase 1b...
Kate Hudson
-
December 31, 2021
0
1
2
3
4
...
6
Page 3 of 6
Recent Post
Hoth Therapeutics ($HOTH) Advances to Phase 2a Trials with New Skin...
Ash K
-
September 5, 2024
0
Hoth Therapeutics, Inc. (NASDAQ: HOTH), a pioneering biopharmaceutical firm, has received significant advancements for its innovative dermatological therapy, HT-001, aimed at treating...
Atara Biotherapeutics (ATRA) Secures Strategic Investments to Advance T-cell Immunotherapy Innovations
September 4, 2024
SPAR Group to Go Private in $2.50 Per Share Buyout by...
September 3, 2024
BioCardia Inc (Nasdaq: BCDA) Achieves Significant FDA Clearance for Morph DNA...
August 29, 2024
XORTX Therapeutics Inc ($XRTX): Pioneering New Treatments for Kidney Disease with...
August 29, 2024